Health Advisory: COVID-19 Antiviral Treatment Underutilization and Changes in How to Access Medications with Commercialization of Oral Antiviral
The New York State Department of Health is reporting a critical underutilization of COVID-19 antiviral treatments among high-risk populations, with only 10% receiving treatment. Effective against current virus strains, these antivirals are crucial in reducing hospitalizations and deaths. Despite their effectiveness, access has shifted to the commercial market, prompting new initiatives to ensure availability at low or no cost, including the Home Test-to-Treat program. Providers are reminded of their role in promptly evaluating and treating COVID-19 patients, emphasizing equitable treatment access. The advisory also notes the importance of prevention through vaccination and provides resources for accessing treatments and assistance programs.
